Sunday, March 22nd from 7:00am – 8:00am PDT

The Expanding Role of FcRn Blockers to Achieve Minimal Symptom Expression in Patients with Generalized Myasthenia Gravis

A CME Symposium in Conjunction with the 2026 California Neurological Society Spring Conference